Literature DB >> 9759556

Osteoporosis in patients with cystic fibrosis.

S M Ott1, M L Aitken.   

Abstract

Decreased bone density and increased risk of fractures are seen in patients with cystic fibrosis. Suboptimal vitamin D levels, nutrition problems, hypogonadism, inactivity, corticosteroid use, and cytokines may contribute to the low bone mass seen in these patients. Treatment recommendations must be individualized and may include nutrition, vitamin D, estrogen or testosterone, and exercise. In high-risk patients calcitonin or growth hormone could be considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759556     DOI: 10.1016/s0272-5231(05)70100-3

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  13 in total

Review 1.  The role of vitamins in cystic fibrosis.

Authors:  S B Carr; J McBratney
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 2.  Bone abnormalities in gastrointestinal and hepatic disease.

Authors:  F A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

3.  Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.

Authors:  Michael P Boyle; Michelle L Noschese; Sharon L Watts; Marsha E Davis; Shane E Stenner; Noah Lechtzin
Journal:  Am J Respir Crit Care Med       Date:  2005-04-28       Impact factor: 21.405

Review 4.  Vitamin D in organ transplantation.

Authors:  E M Stein; E Shane
Journal:  Osteoporos Int       Date:  2011-01-05       Impact factor: 4.507

5.  Lactose malabsorption is a risk factor for decreased bone mineral density in pancreatic insufficient cystic fibrosis patients.

Authors:  Edyta Mądry; Beata Krasińska; Sławomira Drzymała-Czyż; Dorota Sands; Aleksandra Lisowska; Philip Grebowiec; Alina Minarowska; Beata Oralewska; Przemyslaw Mańkowski; Jerzy Moczko; Jarosław Walkowiak
Journal:  Eur J Hum Genet       Date:  2012-03-28       Impact factor: 4.246

6.  A prospective study of change in bone mineral density over one year in adults with cystic fibrosis.

Authors:  C S Haworth; P L Selby; A W Horrocks; E B Mawer; J E Adams; A K Webb
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 7.  Chronic pediatric inflammatory diseases: effects on bone.

Authors:  Anuradha Viswanathan; Francisco A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2007-12-29       Impact factor: 6.514

8.  Short-term calcitriol administration improves calcium homeostasis in adults with cystic fibrosis.

Authors:  S A Brown; D A Ontjes; G E Lester; R K Lark; M B Hensler; A D Blackwood; M J Caminiti; D C Backlund; R M Aris
Journal:  Osteoporos Int       Date:  2003-05-28       Impact factor: 4.507

9.  Inflammatory related changes in bone mineral content in adults with cystic fibrosis.

Authors:  C S Haworth; P L Selby; A K Webb; L Martin; J S Elborn; L D Sharples; J E Adams
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

Review 10.  Management of osteoporosis in adults with cystic fibrosis.

Authors:  Travis M Hecker; Robert M Aris
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.